NGL.Phase3 vs Jin | 23–23 | 50.00% |
NGL.Phase3 vs Dragunov | 20–21 | 48.78% |
NGL.Phase3 vs King | 21–18 | 53.85% |
NGL.Phase3 vs Reina | 18–12 | 60.00% |
NGL.Phase3 vs Heihachi | 18–8 | 69.23% |
NGL.Phase3 vs Yoshimitsu | 17–6 | 73.91% |
NGL.Phase3 vs Hwoarang | 13–10 | 56.52% |
NGL.Phase3 vs Kazuya | 9–13 | 40.91% |
NGL.Phase3 vs Victor | 11–11 | 50.00% |
NGL.Phase3 vs Steve | 12–9 | 57.14% |
NGL.Phase3 vs Jun | 10–11 | 47.62% |
NGL.Phase3 vs Xiaoyu | 11–9 | 55.00% |
NGL.Phase3 vs Bryan | 11–9 | 55.00% |
NGL.Phase3 vs Lidia | 10–10 | 50.00% |
NGL.Phase3 vs Paul | 13–5 | 72.22% |
NGL.Phase3 vs Law | 13–4 | 76.47% |
NGL.Phase3 vs Asuka | 11–5 | 68.75% |
NGL.Phase3 vs Lee | 8–3 | 72.73% |
NGL.Phase3 vs Eddy | 5–6 | 45.45% |
NGL.Phase3 vs Feng | 3–7 | 30.00% |
NGL.Phase3 vs Lili | 1–9 | 10.00% |
NGL.Phase3 vs Leo | 7–3 | 70.00% |
NGL.Phase3 vs Devil Jin | 5–4 | 55.56% |
NGL.Phase3 vs Claudio | 3–6 | 33.33% |
NGL.Phase3 vs Jack-8 | 5–3 | 62.50% |
NGL.Phase3 vs Azucena | 5–3 | 62.50% |
NGL.Phase3 vs Lars | 6–1 | 85.71% |
NGL.Phase3 vs Nina | 3–4 | 42.86% |
NGL.Phase3 vs Kuma | 5–2 | 71.43% |
NGL.Phase3 vs Alisa | 4–1 | 80.00% |
NGL.Phase3 vs Raven | 4–1 | 80.00% |
NGL.Phase3 vs Shaheen | 1–2 | 33.33% |
NGL.Phase3 vs Clive | 2–1 | 66.67% |
NGL.Phase3 vs Panda | 2–0 | 100.00% |
NGL.Phase3 vs Zafina | 2–0 | 100.00% |
NGL.Phase3 vs Leroy | 2–0 | 100.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.